114 - GLP-1 Weight Loss Panel (9 tests)
GLP-1 Weight Loss Panel
Fasting Required
The GLP-1 Weight Loss Panel is a comprehensive blood test that evaluates key metabolic, cardiovascular, thyroid, and nutritional markers before or during GLP-1–based weight loss therapy. This panel provides a broad assessment of blood sugar regulation, insulin resistance, cholesterol balance, thyroid function, and vitamin status to ensure safe and effective progress throughout a weight management program.
It is commonly ordered for individuals beginning GLP-1 medications such as semaglutide or tirzepatide, those with insulin resistance or prediabetes, unexplained weight gain, fatigue, or for ongoing monitoring during medical weight loss and metabolic optimization protocols.
The panel includes 9 tests:
Complete Blood Count (CBC):
Evaluates red and white blood cells to assess anemia, immune status, and overall baseline health
Comprehensive Metabolic Panel (CMP):
Assesses liver function, kidney function, electrolytes, and blood glucose for overall metabolic safety during weight loss treatment
Lipid Panel:
Measures cholesterol levels, including LDL and HDL, to evaluate cardiovascular risk and metabolic health
Hemoglobin A1C:
Provides a 2–3 month average of blood sugar control and helps assess diabetes or prediabetes risk
Thyroid Stimulating Hormone (TSH):
Screens thyroid function, which plays a major role in metabolism, energy, and weight regulation
Free T3:
Active thyroid hormone important for metabolic rate, fat burning, and energy production
Free T4:
Evaluates thyroid hormone production and supports a complete thyroid assessment
Vitamin B12:
Measures B12 status, an essential nutrient for energy, nerve function, and long-term metabolic support during weight loss therapy
Insulin, Fasting:
Assesses baseline insulin levels and helps evaluate insulin resistance, a key driver of weight gain and metabolic dysfunction.
GLP-1 Weight Loss Panel
Fasting Required
The GLP-1 Weight Loss Panel is a comprehensive blood test that evaluates key metabolic, cardiovascular, thyroid, and nutritional markers before or during GLP-1–based weight loss therapy. This panel provides a broad assessment of blood sugar regulation, insulin resistance, cholesterol balance, thyroid function, and vitamin status to ensure safe and effective progress throughout a weight management program.
It is commonly ordered for individuals beginning GLP-1 medications such as semaglutide or tirzepatide, those with insulin resistance or prediabetes, unexplained weight gain, fatigue, or for ongoing monitoring during medical weight loss and metabolic optimization protocols.
The panel includes 9 tests:
Complete Blood Count (CBC):
Evaluates red and white blood cells to assess anemia, immune status, and overall baseline health
Comprehensive Metabolic Panel (CMP):
Assesses liver function, kidney function, electrolytes, and blood glucose for overall metabolic safety during weight loss treatment
Lipid Panel:
Measures cholesterol levels, including LDL and HDL, to evaluate cardiovascular risk and metabolic health
Hemoglobin A1C:
Provides a 2–3 month average of blood sugar control and helps assess diabetes or prediabetes risk
Thyroid Stimulating Hormone (TSH):
Screens thyroid function, which plays a major role in metabolism, energy, and weight regulation
Free T3:
Active thyroid hormone important for metabolic rate, fat burning, and energy production
Free T4:
Evaluates thyroid hormone production and supports a complete thyroid assessment
Vitamin B12:
Measures B12 status, an essential nutrient for energy, nerve function, and long-term metabolic support during weight loss therapy
Insulin, Fasting:
Assesses baseline insulin levels and helps evaluate insulin resistance, a key driver of weight gain and metabolic dysfunction.
